The workshop "Characterizing the Effects of Endocrine Disruptors on Human Health at Environmental Exposure Levels" was held to provide a forum for discussions and recommendations of methods and data needed to improve risk assessments of endocrine disruptors. This article was produced by a working group charged with determining the basic mechanistic information that should be considered when designing models to quantitatively assess potential risks of environmental endocrine disruptors in adults. To reach this goal, we initially identified a set of potential organ system toxicities in males and females on the basis of known and/or suspected effects of endocrine disruptors on estrogen, androgen, and thryoid hormone systems. We used this integrated, systems-level approach because endocrine disruptors have the potential to exert toxicities at many levels and by many molecular mechanisms. Because a detailed analysis of all these untoward effects was beyond the scope of this workshop, we selected the specific end point of testicular function for a more detailed analysis. The goal was to identify the information required to develop a quantitative model(s) of the effects of endocrine disruptors on this system while focusing on spermatogenesis, sperm characteristics, and testicular steroidogenesis as specific markers. Testicular function was selected because it is a prototypical integrated end point that can be affected adversely by individual endocrine disruptors or chemical mixtures acting at one specific site or at multiple sites. Our specific objective was to gather the information needed to develop models in the adult organism containing functional homeostatic mechanisms, and for this reason we did not consider possible developmental toxicities. Homeostatic mechanisms have the potential to ameliorate or lessen the effects of endocrine disruptors, but these pathways are also potential target sites for the actions of these chemicals. Key words: androgen, estrogens, endocrine disruptors, homeostasis, spermatogenesis, testicular steroidogenesis, thyroid hormones. The endocrine system of adult animals is equipped with a set of mechanisms that regulate circulating levels of endogenous hormones. For example, a series of feedback loops involving the hypothalamus, pituitary, and the gonads, adrenals, and thyroid gland regulates the synthesis of sex steroids, glucocorticoids, and thyroid hormones, respectively. At the same time, elimination of these hormones via biotransformation is catalyzed by enzymes in the liver and other sites that are inducible by hormones themselves as well as other agents (1,2). Thus, the adult mammalian organism has several homeostatic mechanisms that maintain the levels of endogenous estrogens, androgens, and thyroid hormones within certain ranges.
The endocrine system of adult animals is equipped with a set of mechanisms that regulate circulating levels of endogenous hormones. For example, a series of feedback loops involving the hypothalamus, pituitary, and the gonads, adrenals, and thyroid gland regulates the synthesis of sex steroids, glucocorticoids, and thyroid hormones, respectively. At the same time, elimination of these hormones via biotransformation is catalyzed by enzymes in the liver and other sites that are inducible by hormones themselves as well as other agents (1, 2) . Thus, the adult mammalian organism has several homeostatic mechanisms that maintain the levels of endogenous estrogens, androgens, and thyroid hormones within certain ranges.
These same homeostatic mechanisms also can dampen or moderate the effects of endocrine disruptors that affect estrogenic, androgenic, or thyroid hormone systems. In addition it is well established that many acute effects of abnormally high or low levels of endogenous hormones are reversible, e.g., normal menstrual cycles resume when women discontinue using contraceptives (2) , and it is reasonable to expect that the same might be true of acute effects of endocrine disruptors. This is in contrast to the developing organism in which feedback mechanisms controlling hormone synthesis and elimination mechanisms controlling hormone degradation may not be fully functional and in which early developmental exposures may lead to irreversible changes. Hence, it seems appropriate to discuss potential effects of endocrine disruptors in the adult separately from those in the developing organism, and this article focuses on the former.
A workshop on characterizing the effects of endocrine disruptors on human health at environmental exposure levels was held to provide a forum for discussions and recommendations of methods and data needed to improve risk assessments of endocrine disruptors. The authors of this article were members of a working group that addressed homeostasis and endocrine function in adults and how perturbations of endocrine homeostasis may lead to disease. The charge to this working group was to determine the basic mechanistic information that should be considered when designing models to quantitatively assess the risks of endocrine disruptors present at environmentally relevant levels. The specific focus was on endocrine disruptors that affect estrogen, androgen, and thyroid hormone systems, but in the broadest conceptual sense. To some extent, the required mechanistic information depends upon the specific end point one wishes to model, and during a 2-day meeting it was dearly impossible to develop a comprehensive list of information required to analyze all possible adverse effects of every potential endocrine disruptor. Therefore, our approach was to consider a variety of potential untoward effects on the basis of our collective knowledge of endocrine mechanisms, to select one we felt was amenable to development of a risk assessment model, and to delineate the information necessary to construct a model. This would provide a starting point for analysis of one Tables 1 and 2 for the female and male, respectively. In addition, potential adverse effects of endocrine disruptors at each site are also given. In many cases, effects at multiple sites and involving multiple mechanisms are listed as having the potential to produce the same effect. For example, a hormonelike effect could be produced directly by an endocrine disruptor with agonist activity occupying a receptor site in the tissue in question. Alternatively, the same action at a tissue site could be produced by an endocrine disruptor acting on the hypothalamicpituitary-gonadal axis to increase endogenous hormone production, or by actions at the liver to decrease elimination of endogenous hormones, etc. Because of the large number of potential effects, each was further ranked as being of high, medium, or low concern. This ranking of effects is admittedly subjective, but it represents a consensus (unanimity in almost all cases) of the working group on the basis of the following criteria: a) the likelihood that the effect would have a substantive impact on reproduction and hence survival of the species; b) the likelihood that the effect would be potentially life threatening to an affected individual; c) the impact of the effect on the quality of life of an individual; and d) the estimated likelihood that environmentally relevant levels of endocrine disruptors are sufficient to actually produce the effect. These criteria were not weighted quantitatively in the ranking process but were considered in toto by members of the working group in reaching their individual levels of concern. To further focus potential future studies, the working group selected a smaller subset of potential effects from Tables 1 and 2 . This selection was performed on the basis of perceived importance for human health and the potential likelihood that quantitative models of the effect could be developed that would be useful for predicting low-dose effects in the human population. In most cases, the effect selected is actually an aggregate response expected to result from the action of an endocrine disruptor at multiple sites. The effects selected were testicular function, endometrial cancer, the female hypothalamic-pituitary-gonadal axis up to and including successful implantation, reproductive senescence in the female, mammary cancer, and adverse effects on the cardiovascular system and bone. Testicular function was subsequently chosen as the effect to consider as a prototype for modeling studies and is discussed at length in the last section of this article. A mammary epithelial cell proliferation and differentiation, induce growth factor production, and alter the expression of proteolytic enzymes and cell adhesive molecules (13, 14) . Breast cancer cells express a diversity of normal and mutated estrogen receptor transcripts which, if translated into functional proteins, could produce receptors with different affinities for natural and synthetic estrogens (15) . In addition, selected estrogen metabolites can lead to the formation of covalent DNA adducts and trigger damage (16) . The possibility that prolonged exposure to endocrine disruptors has an adverse effect on the development of breast cancer requires careful consideration and analysis.
Adverse cardiovascular and skeletal actions. Estrogens protect against atherosclerosis and myocardial infarcts in premenopausal women. The cardiovascular protection of estrogens is mediated indirectly by effects on lipoprotein metabolism, and more recent studies have indicated these hormones may have direct protective actions on vascular smooth muscle and endothelium (17) . Osteoporosis, which primarily affects postmenopausal women, represents a progressive bone loss, reflecting a shift in the balance between cells responsible for bone formation and resorption. In studies using rodents, estrogens inhibit bone loss at relatively low concentrations (18) . Interestingly, both vascular and bone cells have recently been reported to express the newly discovered estrogen receptor P and to have a higher binding affinity for several environmental estrogens (e.g., genistein, coumestrol) than the classical estrogen receptor a (19) (20) (21) . Cardiovascular disease is the leading cause of death in women and fractures in elderly women are a major cause of morbidity and mortality. It thus seems particularly important to elucidate the potential effects of endocrine disruptors, both detrimental and beneficial, on these conditions.
Conceptual Approach to Develop a Model to Analyze Low-Dose Effects of Endocrine Disruptors on Testicular Function
The general process we selected as a prototype for modeling purposes is testicular function, and within that overall process there are three specific functional end points we chose to consider, spermatogenesis, sperm characteristics, and steroidogenesis. Testicular function was selected for several major reasons: a) these are significant biologic end points for the health and quality of life of the individual as well as the survival of the species, b) it should be possible in some cases to obtain human as well as animal data that can be used to corroborate the models one develops, and c) collectively these end points provide an integrated readout of a coordinated biologic system that is subject to endocrine disruption by many toxicants acting at a number of sites and by a variety of mechanisms. This last point might be particularly important for several reasons when considering endocrine disruptors. First, a single endocrine disruptor might affect the male reproductive system at multiple sites, and hence an effect at one of the cumulative end points noted above might occur at a lower dose than an effect at a single target site studied individually. Substantial information on hormone levels should also be included in models of testicular function. Serum levels of the peptide hormones LH, follicle-stimulating hormone, prolactin, and inhibin should be provided, as well as free and protein-bound levels of numerous steroids (testosterone, dihydrotestosterone, androstenedione, estradiol, 17-hydroxyprogesterone). The actual testicular levels of steroids should also be measured, as endocrine disruptors could conceivably affect the two pools of steroid hormones differentially. Sample collection should be performed at multiple times to account for pulsatile hormone secretion, circadian rhythms, and seasonal variations, and these should be incorporated into models. Also, the rates of production of these hormones under various conditions and their rates of degradation are required for a baseline model as well as their binding affinities for plasma and cellular proteins.
In addition to these biochemical measures, morphometric studies should be performed to measure the number of cells present for all major cell types in the testes, to assess the number and nature of cell-cell associations; and mitosis and meiosis (the number and nature of cells at various stages of spermatogenesis).
Although it might be difficult to incorporate information on fertility into quantitative models of risk assessment, it would be important to obtain information on this parameter to see if changes and trends in this parameter appear consistent with the more readily quantifiable measures above. Data on male fertility in both humans and domestic animals should be collected to the degree they are available, but caution must be exercised in interpretation of results. For example, animal breeders are likely to bias this end point by intentionally selecting for high fertility in males. Also, in the case of humans some standard indices of male fertility (e.g., number of offspring) may be difficult to interpret because they are heavily influenced by multiple factors ( (22) .
In addition to considering levels of receptors and their ligands, it is important to consider the cellular context in which these molecules produce their effects. For example, the net cellular effect that results from the binding of a polypeptide hormone to a cell surface receptor may depend on the level of G proteins, enzymes involved in the formation and breakdown of second messengers, etc. (23) . The effects of nuclear receptors may depend upon the levels of coactivators, corepressors, and other proteins involved in transcription control (24) . The levels and activities of these types of factors must also be incorporated into quantitative models.
Finally, factors that affect either the rates of cell proliferation or cell death in the testes must also be included. These could be agents that act via mechanisms directly involving receptors for hormones and autocrine or paracrine factors as well as agents that act by virtue of their chemical or physical properties rather than receptor interactions. These latter agents might include toxicants considered historically under the rubric of reproductive toxicants but that have not previously been thought of as endocrine disruptors.
In terms of defining the magnitude of change that constitutes endocrine disruption, the working group essentially relied on the basic concept of homeostasis. If one views homeostasis as a process to maintain biologic parameters within a normal range, then any change that causes the value of a parameter to fall outside the normal set of values can be considered an adverse effect. In other words, homeostatic mechanisms could not correct for the biologic insult. This is also consistent with the manner in which one considers the values for any biologic parameter in an individual. The physician or the veterinarian knows that values for any parameter vary within the population, and thus he/she considers whether the measured parameter falls within the normal range. Thus the working group considers an adverse effect to be any change in the parameters of a model (e.g., hormone levels, receptor occupancy, steroid clearance) that falls outside the normal range for the species being considered. There are an enormous number of additional factors that could be built into models to assess low-dose effects of endocrine disruptors on testicular function or other biologic end points, and these could not be discussed in depth during a 2-day meeting. The working group thus decided to list factors likely to be of major importance. The major areas to be considered are age, disease, genetic variability, and lifestyle factors. There is substantial literature on many of these factors which would serve to provide specifics for incorporation into models.
There is substantial literature on the effects of age on testicular function in humans and animals. This literature includes information on the three general Environmental Health Perspectives * Vol 107, Supplement 4 * August 1999 end points, sperm production, sperm characteristics, and steroidogenesis, that would be the focus of an integrated model to describe testicular functioning in response to endocrine disruptors.
A large number of diseases affect testicular function either directly or indirectly. However, many of these are not necessarily related to environmental exposures to endocrine disruptors. There is a strong interest in the possible relationship(s) between endocrine disruptors and the increasing incidence of testicular cancer. The working group felt that this specific disease should be explicitly considered.
Experimental studies can be performed with inbred strains of animals to minimize the effects of genetic background, but genetic differences must be included in models designed to predict human health effects. Certainly ethnicity should be included in baseline models, as should genetic variations likely to have major effects on the levels of endocrine disruptors and/or endogenous hormones (e.g., bioactivation or clearance) or their effects (receptor subtypes). The recently announced National Institute of Environmental Health Sciences Environmental Genome Project can be expected to provide useful information about genetic loci of special importance for quantitative modeling purposes.
A variety of lifestyle factors are also of prime importance to a biologic end point such as testicular function, and the literature contains specific information on each of these that could be used for development of models. Specific factors include diet and nutritional status; lifestyle factors such as stress and exercise; geographic location (as temperature and photoperiods can affect testicular function); therapeutic and recreational drug use; and smoking and drinking patterns.
Summary
The use of an integrated biologic read-out such as testicular function is particularly well suited to develop models that can be used to quantitatively assess the effects of endocrine disruptors in adult organisms. This approach is initially more complex than those that focus on more discrete end points such as a single type of receptor-mediated response (e.g., the activation of an individual gene or reporter by an environmental estrogen or androgen). Although the latter can be very valuable for many purposes (e.g., high throughput screening), the use of integrated system end points enables one to model effects at the level of the whole organism. More specifically, an integrated approach a) can incorporate homeostatic mechanisms that cannot be quantitatively incorporated into more discrete end points measured in a single cell type or organ; b) can describe cases in which a single endocrine disruptor may have effects at multiple sites, and possibly via different mechanisms, and thus assess the overall impact of the chemical on function at the organismal level; and c) can develop models that quantitatively describe situations in which endocrine disruptors and reproductive toxicants acting by other mechanisms are both present, since this ultimately represents the real-world scenario.
